
October to December 2023
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $155,098,030 | 7,256 |
| MOLNUPIRAVIR | $142,778,712 | 123,706 |
| PEMBROLIZUMAB | $136,400,840 | 15,941 |
| NIVOLUMAB | $111,311,970 | 15,498 |
| USTEKINUMAB | $110,386,430 | 15,051 |
| NIRMATRELVIR (&) RITONAVIR | $108,163,712 | 90,359 |
| AFLIBERCEPT | $105,320,946 | 107,869 |
| APIXABAN | $92,849,618 | 1,087,411 |
| DUPILUMAB | $91,657,113 | 53,335 |
| DENOSUMAB | $78,220,462 | 307,554 |
| SEMAGLUTIDE | $73,413,348 | 603,700 |
| ADALIMUMAB | $65,850,176 | 90,888 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $38,855,357 | 4,495,562 |
| ATORVASTATIN | $30,534,845 | 3,157,476 |
| PANTOPRAZOLE | $27,578,090 | 2,814,298 |
| ESOMEPRAZOLE | $23,681,203 | 2,171,065 |
| PERINDOPRIL | $15,483,404 | 1,840,404 |
| METFORMIN | $16,584,906 | 1,677,600 |
| ESCITALOPRAM | $8,694,424 | 1,636,842 |
| SERTRALINE | $8,965,812 | 1,540,539 |
| AMLODIPINE | $11,990,523 | 1,317,401 |
| CEFALEXIN | $7,896,502 | 1,279,425 |
| TELMISARTAN | $9,401,709 | 1,181,817 |
| AMOXICILLIN | $5,353,437 | 1,178,616 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,825,869,333 |
| Patients | $773,564,563 |